UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Synthesis and Pharmacological Characterization of C4‑(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)‑2-Amino-4-(1H‑1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu2 Receptor Agonist

Journal of medicinal chemistry, 2015-09, Vol.58 (18), p.7526-7548

2015

Volltextzugriff (PDF)

Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats

The Journal of pharmacology and experimental therapeutics, 2005-03, Vol.312 (3), p.1055-1063

2005

Volltextzugriff (PDF)

Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties

Neuropsychopharmacology (New York, N.Y.), 2010-03, Vol.35 (4), p.855-869

2010

Volltextzugriff (PDF)

Effectiveness of the Veteran X Peer-Led Mental Health Recovery Program: A Quasi-Experimental Study

Psychiatric rehabilitation journal, 2021-12, Vol.44 (4), p.365-372

2021

Volltextzugriff (PDF)

Discovery of a Novel Series of Orally Active Nociceptin/Orphanin FQ (NOP) Receptor Antagonists Based on a Dihydrospiro(piperidine-4,7′-thieno[2,3‑c]pyran) Scaffold

Journal of medicinal chemistry, 2014-04, Vol.57 (8), p.3418-3429

2014

Volltextzugriff (PDF)

The Muscarinic Acetylcholine Receptor Agonist BuTAC Mediates Antipsychotic-Like Effects via the M4 Subtype

Neuropsychopharmacology (New York, N.Y.), 2013-12, Vol.38 (13), p.2717-2726

2013

Volltextzugriff (PDF)

Netorials

Journal of chemical education, 2008-03, Vol.85 (3), p.463

2008

Volltextzugriff (PDF)

Synthesis and Pharmacological Characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-Amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu[subscript 2] Receptor Agonist

Journal of medicinal chemistry, 2016-03, Vol.58 ((18) ; 09, 2015)

2016

Volltextzugriff (PDF)

Synthesis and Pharmacological Characterization of C4-Disubstituted Analogs of 1 S ,2 S ,5 R ,6 S -2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: Identification of a Potent, Selective Metabotropic Glutamate Receptor Agonist and Determination of Agonist-Bound Human mGlu2 and mGlu3 Amino Terminal Domain Structures

Journal of medicinal chemistry, 2015-02, Vol.58 (4), p.1776-1794

2015

Volltextzugriff (PDF)

Synthesis and Pharmacological Characterization of C4-Disubstituted Analogs of 1S,2S,5R,6S‑2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: Identification of a Potent, Selective Metabotropic Glutamate Receptor Agonist and Determination of Agonist-Bound Human mGlu2 and mGlu3 Amino Terminal Domain Structures

Journal of medicinal chemistry, 2015-02, Vol.58 (4), p.1776-1794

2015

Volltextzugriff (PDF)

Organic Nomenclature

Journal of chemical education, 2003-10, Vol.80 (10), p.1223

2003

Volltextzugriff (PDF)

Synthesis and Pharmacological Characterization of C 4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1 R ,2 S ,4 R ,5 R ,6 R )-2-Amino-4-(1 H -1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu 2 Receptor Agonist

Journal of medicinal chemistry, 2015-09, Vol.58 (18), p.7526-7548

2015

Volltextzugriff (PDF)

Organic Nomenclature

Journal of chemical education, 1994-05, Vol.71 (5), p.421

Shaw, David B

1994

Volltextzugriff (PDF)

Inorganic Nomenclature

Journal of chemical education, 1993-12, Vol.70 (12), p.978

Shaw, David B

1993

Volltextzugriff (PDF)

Molecular Mechanisms of Action and In Vivo Validation of an M sub(4) Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties

Neuropsychopharmacology (New York, N.Y.), 2010-03, Vol.35 (4), p.855-869

2010

Volltextzugriff (PDF)

COURSE OF PATIENTS WITH SINUS NODE DISEASE WITH AND WITHOUT PACEMAKERS

Pacing and clinical electrophysiology, 1989-07, Vol.12 (7), p.1259-1259

Shaw, David B

1989

Volltextzugriff (PDF)

COURSE OF PATIENTS WITH SINUS NODE DISEASE WITH AND WITHOUT PACEMAKERS

Pacing and clinical electrophysiology, 1989-07, Vol.12 (7), p.1259-1259

Shaw, David B

1989

Volltextzugriff (PDF)

Discontinuous Change: Leading Organizational Transformation

Nadler, David A

1995

Volltextzugriff (PDF)

THE PRESSURE WAVE FORM IN THE PULMONARY ARTERY

British Heart Journal, 1963-05, Vol.25 (3), p.347-356

Shaw, David B.

1963

Volltextzugriff (PDF)

Carbene complexes. XXIII: Preparation, characterization, and structures of the enetetramine-derived carbenerhodium(I) chloride complexes [RhCl(LR)3], trans-[RhCl(CO)(LR'2)], and [{RhCl(COD)}2{μ-L2(323)R}] [LR2 orR' = CN(R or R')(CH2)2NR(or R') (R = CH2Ph or Et, R' = Me) and L(323)R = CN(R)(CH2)3N(CH2)2N(CH2)3N(R)C (R = CH2Ph)]

Journal of organometallic chemistry, 1993-10, Vol.459 (1-2), p.311-317

1993

Volltextzugriff (PDF)

Diagnosis of chest pain

International journal of cardiology, 1990-09, Vol.28 (3), p.387

Shaw, David B.

1990

Volltextzugriff (PDF)

Prevalence and Morbidity of Heart Block in Devon

BMJ, 1970-01, Vol.1 (5689), p.144-147

1970

Volltextzugriff (PDF)

1 – 25 von 2.150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.962)
Mit Volltextzugriff
(1.800)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.537)
Life Sciences & Biomedicine
(1.250)
Humans
(1.011)
Female
(605)
Male
(534)
Biological And Medical Sciences
(349)
Middle Aged
(325)
Adult
(304)
Medical Sciences
(258)
Aged
(240)
Animals
(220)
Physical Sciences
(189)
Risk Factors
(151)
Neurosciences & Neurology
(135)
Chemistry
(133)
Adolescent
(124)
General & Internal Medicine
(123)
Cardiovascular System & Cardiology
(118)
Biochemistry & Molecular Biology
(116)
Child
(111)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats

Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties

LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders

Effectiveness of the Veteran X Peer-Led Mental Health Recovery Program: A Quasi-Experimental Study

Discovery of a Novel Series of Orally Active Nociceptin/Orphanin FQ (NOP) Receptor Antagonists Based on a Dihydrospiro(piperidine-4,7′-thieno[2,3‑c]pyran) Scaffold

The Muscarinic Acetylcholine Receptor Agonist BuTAC Mediates Antipsychotic-Like Effects via the M4 Subtype

Netorials

Organic Nomenclature

Organic Nomenclature

Inorganic Nomenclature

Molecular Mechanisms of Action and In Vivo Validation of an M sub(4) Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties

COURSE OF PATIENTS WITH SINUS NODE DISEASE WITH AND WITHOUT PACEMAKERS

COURSE OF PATIENTS WITH SINUS NODE DISEASE WITH AND WITHOUT PACEMAKERS

Discontinuous Change: Leading Organizational Transformation

THE PRESSURE WAVE FORM IN THE PULMONARY ARTERY

Diagnosis of chest pain

Prevalence and Morbidity of Heart Block in Devon

Suchergebnisse filtern